Inactive Instrument

NaturalShrimp Incorporated Stock price Other OTC

Equities

SHMP

US63902N1063

Fishing & Farming

Sales 2022 0.03 Sales 2023 0.24 Capitalization 37.3M
Net income 2022 -86M Net income 2023 -16M EV / Sales 2022 4,530,408,855 x
Net Debt 2022 1.91M Net Debt 2023 25.14M EV / Sales 2023 261,602,623 x
P/E ratio 2022
-1.45 x
P/E ratio 2023
-2.14 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 98.63%
More Fundamentals * Assessed data
Dynamic Chart
NaturalShrimp Incorporated Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
NaturalShrimp Incorporated announced that it has received $0.11 million in funding from GHS Investments, LLC CI
NaturalShrimp Incorporated Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
NaturalShrimp Incorporated Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
NaturalShrimp Incorporated cancelled the acquisition of Yotta Acquisition Corporation from a group of shareholders. CI
NaturalShrimp Incorporated Reports Earnings Results for the Full Year Ended March 31, 2023 CI
NaturalShrimp Incorporated Auditor Raises 'Going Concern' Doubt CI
NaturalShrimp Incorporated Enters into Licensing Agreement with Niterra Co., Ltd CI
NaturalShrimp Announces Agreement for the Purchase of Post-Larvae Shrimp Announces Agreement for the Purchase of Post-Larvae Shrimp CI
NaturalShrimp Incorporated Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022 CI
NaturalShrimp, Inc. Announces the Beginning of A Prawn Farm Wastewater Trial in Mackay, Australia CI
NaturalShrimp Incorporated Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022 CI
NaturalShrimp Incorporated entered into a definitive agreement to acquire Yotta Acquisition Corporation from a group of shareholders for approximately $270 million in a reverse merger transaction. CI
NaturalShrimp Incorporated Provides Florida Production Facility Update CI
NaturalShrimp Incorporated Reports Earnings Results for the First Quarter Ended June 30, 2022 CI
More news
Managers TitleAgeSince
Founder - 00-12-31
Chief Executive Officer 76 00-12-31
Director of Finance/CFO 63 15-07-16
Members of the board TitleAgeSince
Chief Executive Officer 76 00-12-31
Director of Finance/CFO 63 15-07-16
Founder - 00-12-31
More insiders
NaturalShrimp Incorporated is a biotechnology aquaculture company. The Company has developed a commercially viable system for growing shrimp in enclosed salt-water systems using technology to produce fresh, naturally grown shrimp, without the use of antibiotics or toxic chemicals. Its systems can be located anywhere to produce gourmet-grade Pacific white shrimp. Its Vibrio Suppression technology utilizes electrocoagulation (a procedure that uses heat from an electric current to destroy abnormal tissue) to kill potential pathogens and harmful bacteria, such as vibrio. The Company's technology platforms combine electrocoagulation and Hydrogas. The electrocoagulation system replaces the need for biofilters and instead applies non-biological, electrical processes and uses electronics to remove ammonia and to control the level of pathogens in an aquaculture system. Its subsidiaries include NaturalShrimp USA Corporation, NaturalShrimp Global, Inc., and Natural Aquatic Systems, Inc.
More about the company
  1. Stock
  2. Equities
  3. Stock NaturalShrimp Incorporated
  4. Stock NaturalShrimp Incorporated - Other OTC